Lynn M. Amon

A blood RNA signature for tuberculosis disease risk: a prospective cohort study

Daniel E. Zak, Adam Penn‐Nicholson, Thomas J. Scriba et al. · The Lancet · 2016 · 817 citations · Full text

Public Health, Immunology, Infectious Diseases +16

A targeted proteomics–based pipeline for verification of biomarkers in plasma

Jeffrey R. Whiteaker, Chenwei Lin, Jacob J. Kennedy et al. · Nature Biotechnology · 2011 · 367 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11

Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease

Thomas J. Scriba, Adam Penn‐Nicholson, Tom Hraha et al. · PLoS Pathogens · 2017 · 256 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response <i>to Mycobacterium tuberculosis</i> in vivo

Alissa C. Rothchild, Gregory S. Olson, Johannes Nemeth et al. · Science Immunology · 2019 · 181 citations · Full text

Life Sciences, Immunology, Microbiology +16

Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma

Hangjun Duan, Jo Nadine Fleming, David K. Pritchard et al. · Arthritis & Rheumatism · 2008 · 125 citations

Medicine, Immunology, Pathology +16